Literature DB >> 30953081

Reply to: Combination of brachytherapy and chemotherapy not superior to pelvic radiotherapy according to GOG-249.

S Marnitz1.   

Abstract

Mesh：

Year:  2019        PMID： 30953081     DOI： 10.1007/s00066-019-01453-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

Review 1.  Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?

Authors:  S Marnitz; C Köhler; N Gharbi; S Kunze; K Jablonska; J Herter
Journal:  Strahlenther Onkol       Date:  2018-08-15       Impact factor: 3.621

2.  Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

Authors:  Marcus E Randall; Virginia L Filiaci; Hyman Muss; Nick M Spirtos; Robert S Mannel; Jeffrey Fowler; J Tate Thigpen; Jo Ann Benda
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

3.  Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.

Authors:  Ellen Stelloo; Remi A Nout; Elisabeth M Osse; Ina J Jürgenliemk-Schulz; Jan J Jobsen; Ludy C Lutgens; Elzbieta M van der Steen-Banasik; Hans W Nijman; Hein Putter; Tjalling Bosse; Carien L Creutzberg; Vincent T H B M Smit
Journal:  Clin Cancer Res       Date:  2016-03-22       Impact factor: 12.531

4.  Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.

Authors:  Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B Ottevanger; Jonathan A Ledermann; Pearly Khaw; Alessandro Colombo; Anthony Fyles; Marie-Helene Baron; Ina M Jürgenliemk-Schulz; Henry C Kitchener; Hans W Nijman; Godfrey Wilson; Susan Brooks; Silvestro Carinelli; Diane Provencher; Chantal Hanzen; Ludy C H W Lutgens; Vincent T H B M Smit; Naveena Singh; Viet Do; Romerai D'Amico; Remi A Nout; Amanda Feeney; Karen W Verhoeven-Adema; Hein Putter; Carien L Creutzberg
Journal:  Lancet Oncol       Date:  2018-02-12       Impact factor: 41.316

5.  Integrated genomic characterization of endometrial carcinoma.

Authors:  Cyriac Kandoth; Nikolaus Schultz; Andrew D Cherniack; Rehan Akbani; Yuexin Liu; Hui Shen; A Gordon Robertson; Itai Pashtan; Ronglai Shen; Christopher C Benz; Christina Yau; Peter W Laird; Li Ding; Wei Zhang; Gordon B Mills; Raju Kucherlapati; Elaine R Mardis; Douglas A Levine
Journal:  Nature       Date:  2013-05-02       Impact factor: 49.962
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.